Tag: #Celltrion
OMLYCLO Biosimilar Launch Expands US Allergy Treatment Options
Celltrion announced the US commercial availability of OMLYCLO on October 5, 2026, introducing a new option for eligible patients....
MedHealth Times shares the latest in healthcare, medical research, and technology, keeping professionals informed and spotlighting ideas shaping the future of care.
© 2026 MEDHEALTH TIMES. All Rights Reserved.
(Don't worry, we won't spam your email.)
